 SALT LAKE CITY--BUSINESS WIRE--PolarityTE, Inc. Nasdaq: PTE, a company focused on transforming the lives of patients by discovering, designing, and developing a range of regenerative tissue products and biomaterials, today announced the agreement by an accredited investor to exercise certain warrants to purchase up to an aggregate of 10,688,043 shares of common stock having an exercise price of 0.624 issued by the company in December 2020. The shares of common stock issuable upon exercise 